Mrs. Temitope Iluyemi, is the Senior Director, Global Government Relations for Africa region at P&G. Temitope, a qualified pharmacist, joined P&G Nigeria in 1998.
In her over 22years career with P&G, she has distinguished herself with a breadth of roles spanning across commercial and corporate functions (Sales, Market strategy and planning, Supply Network operations, External relations, and Government Relations).
In this timeframe, Mrs. Iluyemi has lived and worked from Nigeria, South Africa, Ghana, Togo, and the United States of America delivering significant value to P&G across business disciplines.
Following her assignment in Washington D.C in 2017, she relocated back to Nigeria and her Government relations role was expanded across the 54countries in Africa.
Temitope is a member of the Pharmaceutical Society of Nigeria, sits on several boards & advisory boards including P&G Nigeria, Montserrado B.V, Corporate Council on Africa, Chairman of the Taskforce on Trade facilitation at the US Chamber of commerce and involved in various local community projects. Mrs. Iluyemi is passionate about governance, is a strong gender advocate and passionate about people and national development. She is a keen advocate of the African regional integration and a highly sought-after speaker who has advocated over several global platforms for the integration of African markets and the AfCFTA.
Mrs. Iluyemi was recognized among the Top 50 Leading ladies in Corporate Nigeria 2019, Top50 Leading African Corporate Women in 2021, Women who made impact in 2019 by the Guardian publication and recognized with a Honoris causa doctorate in 2019
Patricia Obozuwa was appointed as the Vice President, Public Affairs, Communications & Sustainability, Africa at The Coca-Cola Company in December 2020. In this role, she leads a team that oversees Government Affairs, thought leadership, media relations, corporate communications and sustainability for the company across the African continent. Prior to this role, Patricia was the Chief Communications & Public Affairs Officer, GE Africa (since 2012). She founded GE Africa’s corporate social responsibility platform, GE Kujenga and established the ‘GE Lagos Garage’ a hub for advanced manufacturing skills development that has produced over 2,400 graduates in Nigeria to date. She was also the founding co-hub leader of the GE Women’s Network for Sub-Saharan Africa. Prior to joining GE, she was Head, External Relations, Nigeria and Corporate Communication Leader, Sub-Saharan Africa at Procter & Gamble (P&G) Before joining P&G in 2005, Patricia was the Arts and Sponsorship Manager for the British Council in Nigeria. Patricia is a Non-Executive Director of The Water Trust, a US-Headquartered Non-Profit Organization operating in East Africa. She teaches teenagers at her local church. She is passionate about gender balance and telling Africa’s ‘full’ story.
Azuka is the Chief Executive Officer of ARC_ESM. She oversees supply chain transformation projects in Nigeria and has also supported other African countries in strengthening their health systems. She is best known for her expertise in engaging governments and development partners, supporting them to prioritize and invest in health supply chain programmes in Africa.
Her work has improved financial investments by the Federal and State governments in Nigeria and co-investments worth over $8,000,000 (Eight Million US Dollars) from the Bill and Melinda Gates Foundation, The Global Fund, and GAVI.
Azuka is well known for the role she plays as a Thought Partner and Advisor to National Ministries of Health in Africa. Beyond government engagements, she has successfully facilitated Public-Private Partnerships for innovative health financing through platforms such as the World Economic Forum and recently ARC.
Currently, she has pioneered the set-up of a first of its kind Membership Platform for the private sector in Nigeria through which private corporates and individual experts have contributed about $750,000 (Seven Hundred and Fifty Thousand US Dollars) to public health programmes within the past four years.
Her ambition is to provide governments and partners with a pragmatic framework for sustainability and country ownership for supply chain delivery. Her most recent aspiration is in advocating for human capital development in Africa and championing a collaboration with MIT Boston, Zaragoza Logistics Centre, Spain, and six local universities in Nigeria to set-up a Pan-African Centre of Excellence for Supply Chain Management.
Julia Spencer serves as the associate vice president of global vaccines public policy, partnerships, and government affairs at Merck. In this role, she leads global public policy and advocacy to expand access to Merck vaccines, and develops and guides policy strategy and tactical implementation programs to achieve maximum population health impact and business growth. Ms. Spencer brings to this role more than 25 years of public health and health policy experience at the local, state, national, and international levels. Ms. Spencer joined Merck in 2014 as the lead for international vaccines public policy. In this role, she oversaw the formation of a dedicated, internationally-focused policy team charged with strengthening partnerships and developing new platforms for evidence-based policy engagement on critical vaccines issues.
Prior to joining Merck, Ms. Spencer served for 15 years as a senior health official in the U.S. Department of Health and Human Services (HHS). Her tenure at HHS included service as the Science Policy Director within the HHS Secretary’s policy, planning, and evaluation office (ASPE). She was responsible for policy coordination, planning, and legislative development focused on the HHS science agencies – Centers for Disease Control and Prevention, Food & Drug Administration, National Institutes of Health, and Office of the Assistant Secretary for Preparedness and Response.
Dr. Jeffrey L. Sturchio is Chairman of the U. S. Corporate Council on Africa and CEO at Rabin Martin, a global health strategy consulting firm. He has also served as President and CEO of the Global Health Council. Before joining the Council in 2009, Dr. Sturchio was vice president of Corporate Responsibility at Merck & Co. Inc., and president of The Merck Company Foundation.
He is also Chairman of the BroadReach Institute for Training and Education and Friends of the Global Fight Against AIDS, TB and Malaria, and a member of the boards of ACHAP and the Science History Institute.
Dr. Sturchio is a visiting scholar at the Institute for Applied Economics, Global Health and the Study of Business Enterprise at The Johns Hopkins University; Senior Associate at the Center for Strategic and International Studies; a principal of the Modernizing Foreign Assistance Network; Fellow of the American Association for the Advancement of Science; a member of the Council on Foreign Relations and the Arthur W. Page Society; and an advisor to amfAR, the Global Health Group at the University of California San Francisco; Intrahealth International; and the Rutgers Global Health Institute. He received an AB in history from Princeton University and a PhD in the history and sociology of science from the University of Pennsylvania. His most recent book is The Road to Universal Health Coverage: Innovation, Equity, and the New Health Economy (edited with I. Kickbusch and L. Galambos, Johns Hopkins University Press, 2019).
Dr. Muyiwa Tegbe is health policy and health financing expert with significant experience working the United States, sub-Saharan Africa, and southeast Asia. He is currently PATH’s Deputy Director for Primary Health Care serving as a technical lead for ideation, development, and implementation of primary health care programs and interventions by PATH. A medical doctor by training with a strong interest in developing financially sustainable health systems that will deliver improvements in population health outcomes and deliver of system value. Prior to joining PATH, provides senior advisory support and thought partnership to country decision-makers to design and implement innovative demand and supply-side financing interventions that increase financial risk protection for populations, increase financing for country health systems and optimize health outcomes. In prior roles, Muyiwa has worked as a consultant to life-sciences and managed care organizations leading evidence generation activities to support better understanding of unmet needs, quality of care access and broad policy impact analyses. He also led the assessments for establishment of provider reimbursement models, conducted business feasibility assessment, and profitability analysis for investor groups, led a large donor funded health financing technical assistance program in Nigeria, amongst others.